SCHEMBL278312

SCHEMBL278312

CC(C)(C)c1cccc(OCc2cncs2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.48
SOD1 P00441 1/20 0.48
PARP15 Q460N3 1/20 0.46
PARP10 Q53GL7 1/20 0.46
LMNA P02545 4/20 0.45
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
HTT P42858 2/20 0.44
SNRNP200 O75643 1/20 0.39
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PKM P14618 2/20 0.38
HSD17B10 Q99714 1/20 0.38
ACACB O00763 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15607658 0.82 PARP15 (0.54) ALOX5PARP15PARP10LMNARAB9A
SCHEMBL12015518 0.81 PARP15 (0.49) PARP15PARP10POLBRAB9AHTT
SCHEMBL18347810 0.81 PARP15 (0.44) ALOX5PARP15PARP10LMNAPOLB
SCHEMBL278404 0.81 L3MBTL1 (0.70) SOD1LMNAPOLBL3MBTL1RAB9A
SCHEMBL17307635 0.79 PARP15 (0.50) ALOX5PARP15PARP10LMNARAB9A
SCHEMBL325899 0.79 PARP15 (0.47) ALOX5SOD1PARP15PARP10L3MBTL1
SCHEMBL15607657 0.77 PARP15 (0.43) ALOX5PARP15PARP10LMNARAB9A
SCHEMBL15474277 0.76 PARP15 (0.47) ALOX5PARP15PARP10L3MBTL1RAB9A
SCHEMBL28406646 0.75 PARP15 (0.46) ALOX5PARP15PARP10LMNAHTT
SCHEMBL13439820 0.74 SOD1 (0.52) ALOX5SOD1LMNAPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133898-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-13 US disclosed
US-8133898-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-13 US disclosed
US-20100137310-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137310-A1 RENIN INHIBITORS REN, ACE, PRSS3 ALOX5 1964/4885SOD1 1616/4885PARP15 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.